We are live on
!
Find out more
EWM
Essex Woodlands Management Portfolio holdings
AUM
$254M
1-Year Est. Return
4.59%
This Fund
S&P 500
This Quarter
Est. Return
+4.91%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$438M
AUM Growth
-$221K
(-0.05%)
Cap. Flow
-$9.54M
Cap. Flow
% of AUM
-2.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$9.34M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$200K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 96.7% |
Similar funds
1W
TSM
LI
LIA
IGM
WWM
MWM
LRIC
Essex Woodlands Management's Q1 2017 Portfolio in Review
As of Q1 2017, Essex Woodlands Management held 10 positions worth $438M, down 0.05% from $438M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2017: portfolio turnover was 0%. Essex Woodlands Management opened no new positions and made no exits, leaving the 10-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 97% a quarter earlier.
- Essex Woodlands Management's biggest Q1 2017 reduction was Entellus Medical, Inc. Common Stock, cutting an estimated $9.34M.
- Essex Woodlands Management's ten largest holdings make up 100% of its $438M portfolio in Q1 2017.
- Essex Woodlands Management opened 0 new positions and closed 0 in Q1 2017.
- Essex Woodlands Management's portfolio value fell 0.05% quarter-over-quarter to $438M.
Based on Essex Woodlands Management's 13F filing for Q1 2017, filed 15 May 2017.